Aspire Biopharma Holdings (ASBP) Asset Utilization Ratio (2026)

Aspire Biopharma Holdings (ASBP) Asset Utilization Ratio (2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	138.81 Bn	130.96 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	86.07 Bn	78.08 Bn	3.93 Bn	0.38
3	Argenx Se	65.47 Bn	60.29 Bn	1.37 Bn	-
4	Moderna	55.64 Bn	50.50 Bn	52.00 Mn	0.20
5	BeOne Medicines	41.99 Bn	36.89 Bn	1.53 Bn	0.69
6	Alnylam Pharmaceuticals	31.68 Bn	28.37 Bn	992.69 Mn	0.90
7	BioNTech SE	27.69 Bn	9.29 Bn	668.28 Mn	0.13
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	0.54
9	Royalty Pharma	27.36 Bn	26.52 Bn	-	0.13
10	Aspire Biopharma Holdings	8.29 Mn	-3.87 Mn	-30,086.00	0.01

Download Data

Date	Value
Jun 30, 2026	0.01